MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,484 | -0.2% | 668 | 0.0% | 0.00% | – |
| Q1 2023 | $15,517 | -97.4% | 668 | -98.4% | 0.00% | -100.0% |
| Q4 2022 | $606,952 | -23.8% | 41,830 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $797,000 | +4.5% | 41,830 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $763,000 | -28.0% | 42,082 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,060,000 | -43.9% | 42,082 | -38.5% | 0.00% | -33.3% |
| Q4 2021 | $1,888,000 | +26.0% | 68,462 | +47.5% | 0.00% | 0.0% |
| Q3 2021 | $1,498,000 | -23.6% | 46,418 | -27.7% | 0.00% | 0.0% |
| Q2 2021 | $1,961,000 | -46.9% | 64,163 | -47.1% | 0.00% | -57.1% |
| Q1 2021 | $3,691,000 | +23.6% | 121,263 | -19.8% | 0.01% | +16.7% |
| Q4 2020 | $2,987,000 | -27.4% | 151,215 | -52.1% | 0.01% | -33.3% |
| Q3 2020 | $4,113,000 | +70.4% | 315,604 | +47.9% | 0.01% | +80.0% |
| Q2 2020 | $2,414,000 | -20.7% | 213,398 | +0.8% | 0.01% | -37.5% |
| Q1 2020 | $3,046,000 | -58.5% | 211,647 | -22.8% | 0.01% | -42.9% |
| Q4 2019 | $7,338,000 | -27.7% | 274,331 | -22.9% | 0.01% | -30.0% |
| Q3 2019 | $10,152,000 | -6.5% | 355,797 | -11.8% | 0.02% | 0.0% |
| Q2 2019 | $10,860,000 | -31.6% | 403,566 | -12.3% | 0.02% | -31.0% |
| Q1 2019 | $15,876,000 | -15.2% | 460,065 | -29.4% | 0.03% | -31.0% |
| Q4 2018 | $18,724,000 | -33.9% | 651,589 | +6.4% | 0.04% | -22.2% |
| Q3 2018 | $28,337,000 | +22.4% | 612,566 | -1.7% | 0.05% | +12.5% |
| Q2 2018 | $23,158,000 | -26.8% | 622,871 | -41.8% | 0.05% | -11.1% |
| Q1 2018 | $31,651,000 | -14.2% | 1,071,096 | +0.5% | 0.05% | -12.9% |
| Q4 2017 | $36,881,000 | -11.5% | 1,066,231 | -7.4% | 0.06% | -12.7% |
| Q3 2017 | $41,676,000 | +50.3% | 1,151,915 | +7.3% | 0.07% | +44.9% |
| Q2 2017 | $27,729,000 | +29.4% | 1,073,117 | -3.8% | 0.05% | +25.6% |
| Q1 2017 | $21,423,000 | +15.4% | 1,115,833 | +0.6% | 0.04% | +8.3% |
| Q4 2016 | $18,571,000 | – | 1,108,720 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |